Shionogi & Co., Ltd.

About Shionogi & Co., Ltd.

Shionogi Inc. is a discovery-based pharmaceutical company committed to identifying unmet medical needs and harnessing science to treat challenging human diseases. Since 1878, their mission has been to develop new treatments to improve patient lives worldwide, addressing global health challenges such as antimicrobial resistance and COVID-19.

Products & Services

Products:Shionogi offers a range of pharmaceutical products, though specific details are not listed in the content. More information is available on their products page.

Novel Antibiotics:Since 1959, Shionogi has focused on discovering and introducing novel antibiotics.

Medications for HIV and Influenza:Shionogi develops novel medications for HIV and influenza.

Clinical Programs for COVID-19 and Other Diseases:Shionogi is involved in clinical programs targeting COVID-19 and other diseases with high unmet needs.

Specialties

Antimicrobial Resistance COVID-19 Treatments HIV Medications Influenza Medications Novel Antibiotics Clinical Trials Drug Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Award T: - FT: Award	A: 375000000 MR: - FA: $375 million FAN: 375000000	D: 2025-01-16 FD: 2025-01-16	1 investors

Award Latest

2025-01-16

$375.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Josh Abramson

Director, IT Business Systems

A

Angelica Acuna

Senior Manager, Human Resources

K

Kathleen DiBernard-Vetter

Executive Assistant, Clinical Development

C

Casey Doremus

Associate Director, Business Analytics

D

Dante Fiorio

Associate Director, Sales Training

B

Bob Marino

Vice President, Business Development

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Shionogi & Co., Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised